Introduction: Black patients with lung cancer receive an operation less often and have worse survival than white patients. Over the past several decades limited resection has become an acceptable alternative to lobectomy in selected cases, and mediastinal lymph node staging is recommended. The Surveillance, Epidemiology, and End Results database was explored to assess whether the type of surgical approach is similar in black and white patients with lung cancer.
Introduction
It has been reported that black patients with lung cancer receive an operation less often 1 and have worse survival 2 than white patients. When a surgical procedure is performed, 1 survival is similar among the two groups, suggesting that the survival disparity is to be partly attributed to the lower rates of surgery among black patients. In clinical practice, significant advances have changed the management of patients with lung cancer over the past several decades. Limited resection has become an acceptable alternative to lobectomy in selected cases, 3 and mediastinal lymph node (LN) staging is recommended by the National Comprehensive Cancer Network because it has been associated with improved survival. 4 It is not known whether the surgical approach has evolved over the years among racially diverse patients. In an attempt to study whether the type of surgical approach is similar in black and white patients with lung cancer, the Surveillance, Epidemiology, and End Results (SEER) database was explored.
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Material and Methods

Treatment
Radiation Therapy. Patients were classified into two categories depending on whether they received radiotherapy (which includes beam radiation, radiation with an unspecified method or source, radioactive implants, and radioisotopes) or did not (categories "none" or "refused").
Surgery. The code 00 for "cancer-directed surgery" was used to classify patients who did not receive surgical treatment, whereas the codes 20, 21, and 22 were used to classify limited resection; 30, 33, and 45 to 48 were used for lobectomy; 55, 56, 65, 66, and 70 were used for pneumonectomy; 12, 13, 15, 19, and 23 to 25 were used for local excision; and 80, 90, and 99 were used for surgery of unknown type. Information on regional LN examination during surgery was also extracted. The data set is anonymous and public; therefore, it is exempt from institutional review.
Statistical Analysis
Chi-square testing and analysis of variance were used to compare characteristics between blacks and whites. The odds of treatment (surgery and/or radiation) in blacks versus whites were calculated using multivariable logistic regression, with race as the dependent variable, overall and by disease stage. Covariates included in the model were age, sex, insurance coverage, marital status, and urban versus rural residence. Stratified models according to insurance status were also run. The log-rank test and multivariable Cox proportional hazards models were used to assess differences in survival by race.
All analyses were conducted using the SAS v9.3 statistical package (SAS Institute Inc., Cary, NC).
Results
There were 80,578 lung cancer cases included in this analysis: 67,191 in whites and 13,387 in blacks (Table 1) . Black patients with lung cancer were younger, presented at a later stage, were less likely to be insured, and were slightly more likely to be males. Black patients underwent significantly more radiation and less surgery than white patients. When a surgical procedure was performed, it was more often limited resection rather than lobectomy for black patients than for whites. A significantly smaller percentage of black patients had their LNs examined at surgery in comparison with whites, and the number of positive LNs as a percentage of the number of LNs examined was significantly higher in black patients than in white patients.
Surgical treatment was administered to black patients significantly less frequently than to white patients overall (OR adjusted [OR adj ] ¼ 0.69, 95% confidence interval [CI]: 0.65-0.74) (Fig. 1A) and according to stage after adjustment for confounders including insurance status. Opposite results were observed when radiation was analyzed overall (OR adj ¼ 1.1, 95% CI: 1.04-1.12) (Fig. 1B) and according to stage, although the results were statistically significant for stages I and II only. Stratification by age groups (age 50 years versus >50 years) or insurance status did not influence the results. Among those who underwent a surgical procedure, black patients were less likely to have their LNs resected overall (OR adj ¼ 0.79, 95% CI: 0.7-0.89) (Fig. 1C) and according to stage.
Survival
Overall survival was significantly worse in black patients than in white patients (log-rank test chisquare ¼ 93.2, p ¼ 0.0001, HR adj ¼ 1.1, 95% CI: 1.0-1.2, p ¼ 0.0001 after adjustment for age, sex, stage, treatment, insurance, marital status, and urban versus rural residence). The difference was present across stages.
Discussion
Racial disparities in the appropriate lung cancer treatment independent from insurance status have been observed. This was particularly evident in stage I, in which surgery is the recommended treatment of choice. Stage I black patients are more often treated with radiation and significantly less likely to be treated with surgery than white patients. When surgically treated, black patients do not undergo LN resection as often as their white counterparts despite national guidelines. These results indicate that more than a decade after the first and only publication showing lower surgical rates in black patients with lung cancer over the age 65 according to SEER-Medicare data, 1 little has changed in the appropriateness of health care delivery in minorities. The inability to administer guideline-concordant care in black patients with lung cancer could be due to a mix of hospital and personal factors, such as the lack of access to experienced surgeons, presence of comorbidities, misconception about surgery, lack of financial resources for copayments, or other health-related cancer care costs. 6 A systematic review of insurance status and lung cancer outcome 7 reported that patients with Medicaid or no insurance had a worse outcome, had their disease diagnosed at a later stage, underwent treatment (surgery or radiation) infrequently, and were unlikely to be treated at a high-volume center or receive guidelineconcordant care when compared with insured patients. However, race was not considered in this meta-analysis. It is also possible that disparities in appropriate treatment represent the final product of a suboptimal patientsurgeon interaction. Further studies on barriers to appropriate treatment in black patients with lung cancer are still needed.
